Alphatec Holdings (ATEC) Net Equity Issued and Repurchased (2015 - 2023)
Alphatec Holdings (ATEC) reported Net Equity Issued and Repurchased of $145.8 million for Q4 2023, up 1369.73% sequentially from $9.9 million in Q3 2023.
Alphatec Holdings (ATEC) Net Equity Issued and Repurchased (2015 - 2023) Analysis & Trends
Alphatec Holdings (ATEC) has 8 years of Net Equity Issued and Repurchased data on file, last reported at $145.8 million in Q4 2023.
- For the quarter ending Q4 2023, Net Equity Issued and Repurchased changed N/A year-over-year to $145.8 million; the trailing twelve-month figure through Dec 2023 stood at $155.7 million (changed N/A YoY), and the FY2023 full-year result was $213.2 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased improved to $145.8 million in Q4 2023, from $9.9 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $145.8 million in Q4 2023 to a low of -$96000.0 in Q4 2019.
- A 4-year average of $36.1 million and a median of $833000.0 in 2020 frame the typical range for Net Equity Issued and Repurchased.
- Across the five-year window, Net Equity Issued and Repurchased tumbled 127.59% in 2019 and surged 111031.25% in 2020, its largest moves.
- Tracing ATEC's Net Equity Issued and Repurchased over 4 years: stood at -$96000.0 in 2019, then surged by 111031.25% to $106.5 million in 2020, then tumbled by 100.01% to -$10000.0 in 2021, then soared by 1457630.0% to $145.8 million in 2023.
- Business Quant data shows ATEC's Net Equity Issued and Repurchased at $145.8 million in Q4 2023, $9.9 million in Q3 2023, and -$10000.0 in Q2 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 12.70 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Alphatec Holdings | 1.26 Bn | 1.12 Bn | 136.48 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 145.75 Mn |
| Dec 31, 2023 | 145.75 Mn |
| Sep 30, 2023 | 9.92 Mn |
| Sep 30, 2023 | 9.92 Mn |
| Jun 30, 2021 | -10,000.00 |
| Jun 30, 2021 | -10,000.00 |
| Mar 31, 2021 | 131.84 Mn |
| Mar 31, 2021 | 131.84 Mn |
| Dec 31, 2020 | 106.49 Mn |
| Dec 31, 2020 | 106.49 Mn |
| Jun 30, 2020 | 546,000.00 |
| Jun 30, 2020 | 546,000.00 |
| Mar 31, 2020 | 833,000.00 |
| Mar 31, 2020 | 833,000.00 |
| Dec 31, 2019 | -96,000.00 |
| Dec 31, 2019 | -96,000.00 |
| Sep 30, 2019 | 672,000.00 |
| Sep 30, 2019 | 672,000.00 |
| Jun 30, 2019 | 1.39 Mn |
| Jun 30, 2019 | 1.39 Mn |